CVC

CORPORATE VC FIRM OF THE YEAR


This award recognises a European Corporate VC firm / team that has outperformed peers, created value and demonstrated truly outstanding investment decision making.

Qualifying criteria

- Open to corporate venture capital / strategic investment firms only
- Firm must have more than 20% portfolio holdings in healthcare and/or life sciences companies
- Firms must have headquarters / offices in Europe
- Period to be judged review is between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Evidence of innovative company creation and deal-making strategies
- Volume and value of investments made in the qualifying timeline
- Number of lead investments made
- Number / quality of successful syndications
- Post-investment strategic earn-outs
 
 
 
BUY TICKETS AND TABLES
 
 

2019 FINALISTS

 

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Johnson & Johnson Innovation

Johnson & Johnson Innovation

M Ventures

M Ventures

Novartis Venture Fund

Novartis Venture Fund

Pfizer Ventures

Pfizer Ventures

UCB Ventures

UCB Ventures

BUY TICKETS AND TABLES